Evidence map›Paper›PMID 36986318›Full record

ArticlePathogens (Basel, Switzerland)2023

Type I Cystatin Derived from

Pathanin Chantree, Mayuri Tarasuk, Parisa Prathaphan, Jittiporn Ruangtong, Mantana Jamklang, Sirilak Chumkiew, Pongsakorn Martviset

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Pathogens (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Type I Cystatin Derived fromMicroorganisms · 2024
    Article
  8. Cystatins from the Human Liver FlukePathogens (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pathanin ChantreeDepartment of Preclinical Science, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand.ORCID 0000-0003-4974-9584
Mayuri TarasukGraduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathumthani 12120, Thailand.
Parisa PrathaphanThammasat University Research Unit in Nutraceuticals and Food Safety, Thammasat University, Pathumthani 12120, Thailand.
Jittiporn RuangtongThammasat University Research Unit in Nutraceuticals and Food Safety, Thammasat University, Pathumthani 12120, Thailand.
Mantana JamklangInstitute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Sirilak ChumkiewInstitute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Pongsakorn MartvisetDepartment of Preclinical Science, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand.ORCID 0000-0003-4168-5950
Thammasat University · THSuranaree University of Technology · TH

Funding

the Thailand Science Research and Innovation Fundamental Fund TUFF 33/2565
6 · The paper itself

Abstract

There is an inverse relationship between the high incidence of helminth infection and the low incidence of inflammatory disease. Hence, it may be that helminth molecules have anti-inflammatory effects. Helminth cystatins are being extensively studied for anti-inflammatory potential. Therefore, in this study, the recombinant type I cystatin (stefin-1) of

Indexed as

anti-inflammationliver flukeNF-κBRAW 264.7stefin-1THP-1

Identifiers

PMID36986318
PMCPMC10051455
OpenAlexW4322741083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.